The dwell position check is an important QA test that should be performed when commissioning a new HDR device. The AAPM Task Group Report TG 56 recommends this accuracy be within +/-2 mm. The curved geometry of the ring applicator makes the verification of dwell position more challenging. Varian is aware that the ring dwell position accuracy is not always within the required limits. They released a brochure in 2010 describing their method of checking the dwell position for ring applicators. They recommend to check each ring individually and to recheck them every 3 months (after source exchange), since the ring's behavior may change over time. In the Brachyvision 8.6 TPS the ring source dwell positions are defined based on the dummy dwell positions. If in practice there is a discrepancy between them, this can alter the delivered dose. Based on this observation we developed an approach to estimate the shift of the source dwell position relative to the corresponding dummy position, as described in the abstract, and a quick check that will be performed quarterly, after the source exchange.
Shift vs. Dwell Position (3 films)
Pos. Three films were exposed for each ring. Positions checked: 2 -16 (even), with 5 mm step size. A test was also performed for the tandem (straight geometry), to assess source position inherent inaccuracy (tol. +/-1mm). For the GammaMed unit we cannot define a variable offset for the dwell positions. For all 3 rings a proximal 2 mm offset was considered for the quarterly test, to compensate for the distal shift and also to take into account the inherent source position inaccuracy. Shifts remained stable for 2 quarters. For a standard ring loading the dwell positions used for treatment are 3 -6 and 12 -15. We have started to analyze the treatment plans (the dose to the A right/left points, D2cc bladder/rectum) to see the dosimetric effect of the dwell position shift in the ring. For the eleven treatment plans analyzed to date it was found that the dose change for the A right and A left points is within 0.8% and 1.3%, respectively. The maximum increase for bladder and rectum D2cc is 1.8% and 1.3%, respectively. The dose to the A right point increases, the dose to the A left point decreases, while D2cc for bladder/rectum can either increase or decrease, depending of the patient anatomy and hot spots location. Doctors will decide if these effects have clinical significance and if we should correct for the ring dwell positions shift.
